The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Peripheral Artery Disease Global Market Report 2023, The global peripheral artery disease market is expected to grow from $3.67 billion in 2022 to $3.97 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The size of peripheral artery disease market is expected to reach $5.27 billion in 2027 at a CAGR of 7.3%.

What was the major driver in the peripheral artery disease market?
The rise in the prevalence of peripheral artery diseases is expected to propel the growth of the peripheral artery disease market going forward. Peripheral artery disease refers to the narrowing or blockage of arteries outside the heart, usually in the legs, resulting in reduced blood flow and potential complications. Peripheral artery disease treatment helps reduce peripheral artery disease symptoms, enhance mobility, and decrease the risk of severe complications that improve patients’ well-being. For instance, in April 2023, according to HMP Communications LLC, a US-based patient-centered education resource, the global prevalence of peripheral artery disease increased from 11.3 million in 1995 to 21 million in 2020 and estimated to reach 23.8 million by 2030. Therefore, the rise in the prevalence of peripheral artery diseases is driving the growth of the peripheral artery disease market.

View More On The Peripheral Artery Disease Market Report 2023 – https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

What was the key trend in the peripheral artery disease market?
Technological advancements are a key trend gaining popularity in the peripheral artery disease market. Major companies operating in the peripheral artery disease market are adopting technologically advanced surgery treatments to sustain their position in the market. For instance, in November 2022, Genesis MedTech Group, a Singapore-based medical device company, introduced chocolate touch paclitaxel DCB catheter, a percutaneous transluminal angioplasty (PTA) catheter for the treatment of patients with superficial femoral artery and popliteal artery disease. The Chocolate Touch drug-coated balloon is the first and only balloon catheter in the device that combines therapeutic agent administration with a next-generation angioplasty platform for treating peripheral artery disease. It uses pillow-like structures covered with a therapeutic chemical to open in tiny parts to offer an alternate therapy to standard drug-coated balloon angioplasty for individuals suffering from peripheral artery disease. As a result, the balloon surface increases, allowing for more effective medication delivery to the vessel wall and eliminating the requirement for permanent implants.

Which was the largest region in the peripheral artery disease market?
North America was the largest region in the peripheral artery disease market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in peripheral artery disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the peripheral artery disease market prominent players?
Major players in the peripheral artery disease market are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, Natus Medical Inc., AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Lombard Medical Inc., Avinger Inc., and Ra Medical Systems Inc.

Key peripheral artery disease market segments
The global peripheral artery disease market is segmented –
1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories
2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents
3) By Route of Administration: Oral, Parenteral, Other Routes of Administration
4) By End Users: Hospitals, Specialty Clinics, Other End Users

Request A Sample Of The Global Peripheral Artery Disease Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12068&type=smp

The Peripheral Artery Disease Global Market Report 2023  provides a comprehensive overview on the peripheral artery disease market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Coronary Artery Disease Global Market Report 2023
Anticoagulants Global Market Report 2023
Vascular Grafts Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model